The U.S. semiconductor industry faces increasing competition from overseas, but the government hopes a new panel of experts can go some way to ensuring that it maintains its dominance in the coming years.
The domestic industry still isn’t in bad shape: according to the White House, it still employs 250,000 workers and is the third-largest source of manufactured exports in the country. And Intel remains the world’s biggest chipmaker. But its competitive advantage has certainly been slipping.
That’s down to two main factors. First, the likes of Intel and AMD pulled up short on designs for mobile chips, an area now dominated by companies that specialize in low-power processors, such as ARM. Second, even when American companies, such as Apple, design chips that are built by U.S.-based organizations, like Globalfoundries, the hardware itself is now often manufactured overseas.
There are other threats looming, too. China, in particular, is pumping $100 billion into subsidizing its own semiconductor market, while the slowing of Moore’s Law is causing industrywide headaches of its own.
The new working group—made up of industry veterans from the likes of Intel, Qualcomm, and Microsoft—will seek to overcome some of those issues. John Holdren, director of the Office of Science and Technology Policy at the White House, explained in a statement that the group would “identify the core challenges facing the semiconductor industry at home and abroad and identify major opportunities for sustaining U.S. leadership.”
In reality, that will mean finding potential new strategies—from radical new geometries and optical computing approaches, to increasingly specialized chips—and then investing heavily. Some of that will be private, such as Samsung’s new commitment to invest $1 billion into its semiconductor facilities in Austin, Texas, but plenty will come from the government, too.
The all-American iPhone may remain somewhat of a fantasy for now, but at least a few more of its internal chips could end up being manufactured on home turf.
Meta has built a massive new language AI—and it’s giving it away for free
Facebook’s parent company is inviting researchers to pore over and pick apart the flaws in its version of GPT-3
The gene-edited pig heart given to a dying patient was infected with a pig virus
The first transplant of a genetically-modified pig heart into a human may have ended prematurely because of a well-known—and avoidable—risk.
Saudi Arabia plans to spend $1 billion a year discovering treatments to slow aging
The oil kingdom fears that its population is aging at an accelerated rate and hopes to test drugs to reverse the problem. First up might be the diabetes drug metformin.
Yann LeCun has a bold new vision for the future of AI
One of the godfathers of deep learning pulls together old ideas to sketch out a fresh path for AI, but raises as many questions as he answers.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.